- 76 -
3.3. Referências
[1] Goodwin, S., Smith, A F. and Horning, E. C.. J. Am. Chem. Soc. 1959, 81, 1903-
1908; Woodward, R. B., Iacobucci, G. A. and Hochstein, F. A.. J. Am. Chem. Soc.
1959, 81, 4434-4435.
[2] Gribble, G. W., in The Alkaloids, (Academic Press, 1990) Vol. 39, p.239.
[3] E. M. Acton, V. L. Narayanan, P.A. Risbood, R. H. Shoemaker, D. T. Vistica and
M. R. Boyd, J. Med. Chem 37, 2185-2189 (1994).
[4] M. Sainsburg in The Chemistry of Antitumor Agents, D. E. V. Wilman (Ed.),
Chapman and Hall, N. Y., 1990, p.410.
[5] C. Auclair, Archives of Biochemmistry Biophysics 259, 1-14 (1987).
[6] Auclair, C.. Arch. Biochem. Biophys. 1987, 259, 1.
[7] Anderson, W. K., Gopalsamy, A. and Reddy, P. S.. J. Med. Chem. 1994, 37,
1955-1963; Jurayj, J., Haugwitz, R. D., Varma, R. K., Paull, K. D., Barret, J. F and
Cushman, M.. J. Med. Chem. 1994, 37, 2190-2197.
[8] Paoletti, C., Cros, S., Dat-Xuong, N., Lecointe, P., and Moisand, A.. Chem. Biol.
Interact. 1979, 25, 45-58.
[9] Chabane, H., Lamazzi, C., Thiéry, V., Guillaumetb, G. and Bessona, T..
Tetrahedron Letters 2002, 43, 2483–2486.
[10] Tran-Thi, H. A., Nguyen-Thi, T., Michel, S., Tillequin, F., KOCH, M., Pfeiffer, B.,
Pierré, A., Trinh-Van-Dufat, H.. Chem. Pharm. Bull. 2004, 52, 540-545.
[11] Ergun, Y., Patir, S., Okay, G.. Synthetic Communications. 2004, 34, 435-442.
[12] Ishikura, M., Hino, A., Yaginuma, T., Ágata, I. and Katagiri, N.. Tetrahedron
2000, 56, 193–207.
[13] Diaz, M., Cobas, A., Guitian, E., Castelo, L.. European Journal of Organic
Chemistry 2001, 23, 4543-4549.
[14] Ishikura, M., Hino, A., Katagiri, N.. Heterocycles 2000, 53, 11-14.
[15] Villemin, D.; Cherqaoui, D.; Mesbah, A.. J. Chem. Inf. Comput. Sci. 1994, 34,
1288-1293.
[16] Cavaliere, E. L.; Rogan, E. G.; Roth, R. W.; Saugier, R. K.; Hakam, A.. Chem.
Biol. Interact. 1983, 47, 87-109.
[17] Richard L. Edelson, Light Activated Drugs, Scientific American, 1988.